<qa>  What is the major morbidity of this procedure?Prostate brachytherapy is an increasingly popular method of treating clinically localized prostate cancer. The major morbidity of this procedure is obstructive and irritative voiding symptoms. The risk of urinary retention in published series is 10-15. Voiding symptoms persist up to 1 year following this procedure. 